Roche’s Spark unit blueprints $575M gene therapy manufacturing center in Phillynews2021-12-17T15:47:05+00:00December 17th, 2021|FierceBiotech|
2022 forecast: Talent war in life sciences, salary inflation in C-suite builds to ‘negative feedback loop’news2021-12-16T23:58:08+00:00December 16th, 2021|FierceBiotech|
Precisely targeting liver cancer with logic-gated gene therapynews2021-12-16T12:03:45+00:00December 16th, 2021|FierceBiotech|
Abbott gifts $1M to Howard University in effort to diversify clinical trialsnews2021-12-15T15:58:13+00:00December 15th, 2021|FierceBiotech|
Abbott gifts $1M to Howard University in effort to diversify clinical trialsnews2021-12-15T15:58:13+00:00December 15th, 2021|FierceBiotech|
FHI Clinical acquires South African CRO to expand global footprintnews2021-12-15T15:26:03+00:00December 15th, 2021|FierceBiotech|
FHI Clinical acquires South African CRO to expand global footprintnews2021-12-15T15:26:03+00:00December 15th, 2021|FierceBiotech|
Turns out Galera’s radiotherapy complication drug did work after all, and investors are thrillednews2021-12-14T19:21:57+00:00December 14th, 2021|FierceBiotech|
Preventing cancer metastasis by keeping dormant tumor cells asleep with collagennews2021-12-13T14:52:39+00:00December 13th, 2021|FierceBiotech|
UPDATE: Pfizer books Arena for immuno-inflammatory portfolio in $6.7B dealnews2021-12-13T14:12:49+00:00December 13th, 2021|FierceBiotech|
